Semaglutide Modulates Extracellular Matrix Production of LX-2 Cells via Exosomes and Improves Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD).

MLA

Scavo, Maria Principia, et al. “Semaglutide Modulates Extracellular Matrix Production of LX-2 Cells via Exosomes and Improves Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD).” International Journal of Molecular Sciences, vol. 25, no. 3, Feb. 2024, p. 1493. EBSCOhost, https://doi.org/10.3390/ijms25031493.

APA

Scavo, M. P., Lisco, G., Depalo, N., Rizzi, F., Volpe, S., Arrè, V., Carrieri, L., Notarnicola, M., De Nunzio, V., Curri, M. L., De Pergola, G., Piazzolla, G., & Giannelli, G. (2024). Semaglutide Modulates Extracellular Matrix Production of LX-2 Cells via Exosomes and Improves Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD). International Journal of Molecular Sciences, 25(3), 1493. https://doi.org/10.3390/ijms25031493

Chicago

Scavo, Maria Principia, Giuseppe Lisco, Nicoletta Depalo, Federica Rizzi, Sara Volpe, Valentina Arrè, Livianna Carrieri, et al. 2024. “Semaglutide Modulates Extracellular Matrix Production of LX-2 Cells via Exosomes and Improves Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD).” International Journal of Molecular Sciences 25 (3): 1493. doi:10.3390/ijms25031493.